These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1603565)

  • 1. Oriental sore: a case report.
    Asvesti C; Anastassiadis G; Kolokotronis A; Zographakis I
    Oral Surg Oral Med Oral Pathol; 1992 Jan; 73(1):56-8. PubMed ID: 1603565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmaniasis of the lip.
    Veraldi S; Rigoni C; Gianotti R
    Acta Derm Venereol; 2002; 82(6):469-70. PubMed ID: 12575860
    [No Abstract]   [Full Text] [Related]  

  • 3. Case report: Leishmaniasis of the upper lip.
    Veraldi S; Bottini S; Persico MC; Lunardon L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Nov; 104(5):659-61. PubMed ID: 17656118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous lupoid leishmaniasis: a case report.
    Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
    Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind randomized clinical trial of a topical herbal extract (Z-he) vs. systemic meglumine antimonate.
    Momeni AZ; Aminjavaheri M
    Int J Dermatol; 2000 Nov; 39(11):880. PubMed ID: 11123462
    [No Abstract]   [Full Text] [Related]  

  • 6. American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis resistant to meglumine antimoniate, but with good response to pentamidine: a case report.
    Pimentel MI; Baptista C; Rubin EF; Vasconcellos Ede C; Lyra MR; Salgueiro Mde M; Saheki MN; Rosalino CM; Madeira Mde F; Silva AF; Confort EM; Schubach Ade O
    Rev Soc Bras Med Trop; 2011; 44(2):254-6. PubMed ID: 21552747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralesional injections of meglumine antimoniate to treat complex facial leishmania infantum acquired in Spain: a case report.
    Mostmans Y; Van Gysel J; Vanden Nest H; Mervillie K; Richert B; Clevenbergh P
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e548-e550. PubMed ID: 35181939
    [No Abstract]   [Full Text] [Related]  

  • 8. Old-world leishmaniasis of the auricle.
    Skevas A; Kastanioudakis I; Bai M; Kostoula A
    Lancet; 1997 Jan; 349(9044):28-9. PubMed ID: 8988123
    [No Abstract]   [Full Text] [Related]  

  • 9. [Infiltrated plaque on the lip].
    Litaiem N; Jaber K; El Khalifa J; Kaabi W; Soumaya Y; Dhaoui MR; Doss N
    Ann Dermatol Venereol; 2013; 140(8-9):547-8. PubMed ID: 24034642
    [No Abstract]   [Full Text] [Related]  

  • 10. Disseminated cutaneous leishmaniasis: a patient with 749 lesions.
    Sousa AQ; Pompeu MM; Sólon FR; Frutuoso MS; Teixeira MJ; Silva TM
    Braz J Infect Dis; 2006 Jun; 10(3):230. PubMed ID: 17568857
    [No Abstract]   [Full Text] [Related]  

  • 11. [Erysipeloid cutaneous leishmaniasis: about a clinical observation].
    El kartouti A; Elbenaye J; Miloudi M
    Pan Afr Med J; 2015; 21():54. PubMed ID: 26405490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of meglumine antimoniate in canine leishmaniasis.
    Lamothe J
    Vet Rec; 2004 Mar; 154(12):378. PubMed ID: 15074332
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of miltefosine for the treatment of American cutaneous leishmaniasis.
    Vélez I; López L; Sánchez X; Mestra L; Rojas C; Rodríguez E
    Am J Trop Med Hyg; 2010 Aug; 83(2):351-6. PubMed ID: 20682881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of cutaneous leishmaniasis (chiclero's ulcer) to treatment with meglumine antimoniate in Southeast Mexico.
    Vargas-Gonzalez A; Canto-Lara SB; Damian-Centeno AG; Andrade-Narvaez FJ
    Am J Trop Med Hyg; 1999 Dec; 61(6):960-3. PubMed ID: 10674678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
    J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [N-methyl glucamine antimoniate or Glucantime].
    Rapp C; Simon F; Dordain ML
    Med Trop (Mars); 2000; 60(4):342-3. PubMed ID: 11436584
    [No Abstract]   [Full Text] [Related]  

  • 17. [Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy].
    Yeşilova Y; Turan E; Sürücü HA; Aksoy M; Özbilgin A
    Turkiye Parazitol Derg; 2015 Mar; 39(1):63-5. PubMed ID: 25917587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B.
    Spinicci M; Zammarchi L; Gramiccia M; Di Muccio T; Bartolozzi D; Corsi P; Trotta M; Bartoloni A
    J Travel Med; 2021 Aug; 28(6):. PubMed ID: 32918547
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison Of Efficacy Of Miltefosine Versus Meglumine Antimonate In The Treatment Of Cutaneous Leishmaniasis.
    Mohammad N; Sagheer F; Paracha MM; Khan AQ; Naseem S; Wasim M
    J Ayub Med Coll Abbottabad; 2022; 34(4):849-853. PubMed ID: 36566412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.